Managing risk from conflicts of interest in guideline development committees
BMJ
.
2022 Dec 6:379:e072252.
doi: 10.1136/bmj-2022-072252.
Authors
Lisa Parker
1
,
Lisa Bero
2
Affiliations
1
School of Pharmacy, Charles Perkins Centre, University of Sydney, New South Wales, Australia.
2
Center for Bioethics and Humanities, University of Colorado Anschutz Medical Campus, Colorado, USA Lisa.bero@cuanschutz.edu.
PMID:
36593553
DOI:
10.1136/bmj-2022-072252
No abstract available
MeSH terms
Conflict of Interest*
Disclosure
Humans
Risk Management*